2010
DOI: 10.1167/iovs.09-4437
|View full text |Cite
|
Sign up to set email alerts
|

Compound Heterozygosity of Two Novel Truncation Mutations inRP1Causing Autosomal Recessive Retinitis Pigmentosa

Abstract: Purpose. To evaluate the phenotypic effects of two novel frameshift mutations in the RP1 gene in a Chinese pedigree of autosomal recessive retinitis pigmentosa (ARRP). Methods. Family members of a proband with ARRP were screened for RP1, RHO, NR2E3, and NRL mutations by direct sequencing. Detected RP1 mutations were genotyped in 225 control subjects. Since one family member with the RP1 deletion mutation in exon 2 was found to have age-related macular degeneration (AMD) but not RP, exons 2 and 3 of RP1 were sc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
54
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(58 citation statements)
references
References 39 publications
4
54
0
Order By: Relevance
“…It has been suggested that RP due to mutations in RP1 is a result of haploinsufficiency, but our previous observation that carriers of the recessive p.A221G fs X20 mutation in exon 3 (predicted to be subjected to NMD) were asymptomatic suggests an alternative mechanism. This is further supported by the report of compound heterozygosity in arRP, where carriers of one allele predicted to be subjected to NMD were also asymptomatic 26. The four novel arRP protein truncating mutations we describe are downstream of the DCX domain and carrier individuals show no evidence of a retina phenotype (figure 3) suggesting each allele in a heterozygous state is not acting in a dominant negative manner, and one normal allele is sufficient for retina function.…”
Section: Discussionsupporting
confidence: 80%
“…It has been suggested that RP due to mutations in RP1 is a result of haploinsufficiency, but our previous observation that carriers of the recessive p.A221G fs X20 mutation in exon 3 (predicted to be subjected to NMD) were asymptomatic suggests an alternative mechanism. This is further supported by the report of compound heterozygosity in arRP, where carriers of one allele predicted to be subjected to NMD were also asymptomatic 26. The four novel arRP protein truncating mutations we describe are downstream of the DCX domain and carrier individuals show no evidence of a retina phenotype (figure 3) suggesting each allele in a heterozygous state is not acting in a dominant negative manner, and one normal allele is sufficient for retina function.…”
Section: Discussionsupporting
confidence: 80%
“…First, we evaluated the family of an adult patient with recessive RP due to a homozygous mutation in exon 3 of RP1 , which is predicted to be null. The sibling and parents of this patient, who all carry a single mutant RP1 allele, do not exhibit evidence of RP, confirming that functional hemizygosity of RP1 does not cause disease [41]. Next, we generated and characterized Rp1 knock-in mice with a Q662X nonsense point mutation in exon 4 of human RP1 .…”
Section: Introductionmentioning
confidence: 58%
“…In that family, the carrier of the p.S2RfsX16 allele, which creates a premature termination codon in exon 2, did not show evidence of RP either [41]. Since the nonsense mutations, c.5_6delGT (p.S2RfsX16, exon 2) and c.686delC (p.P229QfsX35, exon 3), occur in the 2 nd or 3 rd rather than the final exon in these two families, they are expected to lead to NMD of the mutant mRNAs, and thus create null alleles [43].…”
Section: Resultsmentioning
confidence: 88%
See 1 more Smart Citation
“…The numerous deletions and insertions can be explained by the multiple A nucleotides flanking the mutation sites, possibly causing slipped strand mispairing during replication [43]. Chen et al proposed four classes of RP1 mutations [44]. Truncations located between amino acid 500 and 1053 within the last exon are NMD-insensitive and belong to ‘Class II’ mutations, making up the majority of PTC mutations.…”
Section: Sequence and Copy Number Variationsmentioning
confidence: 99%